| Literature DB >> 29081660 |
Giampiero Avruscio1, Ilaria Tocco-Tussardi1,2, Greta Bordignon3, Vincenzo Vindigni2.
Abstract
BACKGROUND: Chronic vascular wounds have a significant economic and social impact on our society calling for allocation of a great deal of attention and resources. Efforts should be oriented toward the achievement of the most effective and efficient clinical management. The Angiology Unit at the University Hospital of Padova, Italy, developed a performance improvement project to enhance the quality of practice for vascular ulcers.Entities:
Keywords: chronic wounds; clinical process management; cost-effectiveness; vascular ulcers
Mesh:
Year: 2017 PMID: 29081660 PMCID: PMC5652916 DOI: 10.2147/VHRM.S137099
Source DB: PubMed Journal: Vasc Health Risk Manag ISSN: 1176-6344
Prevalence of chronic wound problems among people receiving community health assistance in the province of Padua (IT) (~920,200 inhabitants)
| Health care assistance | No of people assisted | Pressure ulcers
| Vascular ulcers
| Diabetic foot ulcers | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Stage I | Stage II | Stage III | Stage IV | Eschar | Missing data | Total | Venous | Arterial | Mixed | Not defined | Missing data | ||||
| Home care assistance | 2,182 | 495 (22.7%) | 66 (13.3%) | 221 (44.6%) | 130 (26.3%) | 39 (7.9%) | 8 (1.6%) | 31 (6.3%) | 401 (18.4%) | 140 (34.9%) | 38 (9.5%) | 103 (25.7%) | 105 (26.2%) | 15 (3.7%) | 94 (4.3%) | 991 (45.4%) |
| Elderly care (facilities) | 3,838 | 265 (6.9%) | 60 (22.8%) | 103 (38.7%) | 80 (30.2%) | 15 (5.7%) | 2 (0.6%) | 5 (2%) | 65 (1.7%) | 23 (34.8%) | 10 (15.2%) | 12 (18.2%) | 14 (21.2%) | 6 (10.6%) | 15 (0.4%) | 430 (11.2%) |
| Total | 6,020 | 760 (12.6%) | 466 (7.7%) | 109 (1.8%) | 1,421 (23.6%) | |||||||||||
Note:
Percent on the total of lesions.
Synopsis of the project for improvement of clinical management for vascular wounds
| Phase | Main action | Dedicated time (h)
| |||||
|---|---|---|---|---|---|---|---|
| Project director | Expert A | Expert B | Participants | Coordinator | Method | ||
| Phase I: global assessment of wound care system status | A | 4 | 10 | 10 | 10 | Medical and nursing staff conjoint meetings. | |
| B | 2 | 10 | 10 | 10 | Questionnaires | ||
| C | 10 | 10 | 10 | 10 | Visit of local health districts. | ||
| D | 14 | 1 | 14 | 14 | 14 | Lectures. | |
| Phase II: development of a new standardized protocol | A | 10 | 10 | 10 | 10 | Small-group workshops. | |
| B | 2 | 20 | 20 | 20 | Small-group workshops. | ||
| Phase III: application of the new protocol | Application of the new routine including clinical and administrative changes. | 15 | 2 | 40 | 40 | On-the-job monitoring. | |
| Phase IV: review of outcome indicators | Analysis of results with regards to outcome indicators. | 7 | 7 | 7 | 7 | Small-group workshops. | |
| Total dedicated time (h) | 64 | 1 | 83 | 121 | 121 | ||
Notes: Detection of involved health care professionals: Project director: Director of the Angiology Unit at the University Hospital of Padua; Expert A: 1 vascular surgeon and 1 registered nurse who has been working in chronic wound care for 10 years; Expert B: health care specialists (4 specialists in Angiology, 1 vascular surgeon, 1 phlebologist, 1 general surgeon, 1 specialist in long-term hospital care, 1 microbiologist, 1 anesthesiologist, 1 dermatologist, 1 specialist in Forensic Medicine, 1 plastic surgeon, and 1 registered nurse who has been working in chronic wound care for 5 years).
Figure 1Algorithm of management for peripheral arterial disease.
Abbreviations: TcpO2, transcutaneous oxygen; TcpCO2, transcutaneous carbon dioxide.
Figure 2Algorithm of management for venous disease.
Note: *Hospitalization was recommended for patients with massive deep venous thrombosis, with symptomatic pulmonary embolism, at high risk of anticoagulant bleeding, or with major comorbidity.
Results of the project with referral to outcome indicators
| Health care professional group | Outcome indicator | Result | Remark |
|---|---|---|---|
| Physicians | Standardization of clinical data collection | Partially achieved | Requires further standardization of data entry into the computer system |
| Consensus on treatment modalities | Achieved | ||
| Harmonization of use of products and devices | Achieved | ||
| Computerization of clinical documentation | Achieved | ||
| Nurses | Harmonization of knowledge on the management of vascular lesions | Partially achieved | Requires consolidation of bandaging skills |
| Standardization of practice | Partially achieved | Requires continuous education to reach equal competences | |
| Computerization of clinical records | Achieved | ||
| Administrators | Increase of knowledge of the multiple needs of patients | Achieved | |
| Strengthen connections with Community Services | Partially achieved | Requires implementation of the connection and standardization of practice in order to ameliorate the continuity of wound care |
Difference in costs related to wound care between the year before and the year after the project
| Costs related to wound care | 2014 | 2015 | Difference |
|---|---|---|---|
|
| |||
| € | € | € (%) | |
| Fixed costs for hospital care | 6,400.65 | 5,233.83 | 1,166.82 (18.2) |
| Variable costs (extra supplies as listed below) | 14,215.35 | 1,952.2 | 12,263.18 (86.3) |
| Total | 20,616 | 7,186 | 13,430 (56.1) |
| Average cost per treatment | 6.57 | 2.25 | 4.32 (65.7) |
| Average cost per patient | 65.86 | 22.53 | 43.33 (65.8) |
| Extra supplies | |||
| AQUACEL® Extra™ Dressing 10 × 10 cm | 10.2 | 25.5 | 15.3 (150) |
| AQUACEL® Extra™ AG Dressing 10 × 10 cm | 246.4 | 369.6 | 123.2 (50) |
| Mepitel® Soft Silicone Wound Contact Layer Dressing 5 × 7.5 cm | 229.2 | 191 | 38.2 (16.7) |
| Mepitel® Soft Silicone Wound Contact Layer Dressing 7.5 × 10 cm | 255 | 53.55 | 201.45 (79) |
| Mepilex® Foam Dressing 10 × 10 cm | 1,656 | 1,620 | 36 (2.2) |
| Mepilex® Foam Dressing 15 × 15 cm | 91.5 | 0 | 91.5 (100) |
| Acticoat™ Flex 3 Antimicrobial Barrier Dressing | 5,743.8 | 0 | 5,743.8 (100) |
| ALLEVYN Non-Adhesive Hydrocellular Polyurethane Dressing 10 × 10 cm | 108.8 | 0 | 108.8 (100) |
| ALLEVYN Non-Adhesive Hydrocellular Polyurethane Dressing 20 × 20 cm | 151.2 | 20.4 | 130.8 (86.5) |
| ALLEVYN Anatomically Shaped Hydrocellular Dressing Allevyn Heel dressing 10 × 13.5 cm | 53.75 | 0 | 53.75 (100) |
| ACTISORB™ Silver 220 Antimicrobial Binding Dressing 10.5 × 10.5 cm | 2,267.3 | 200.9 | 2,066.4 (91.1) |
| ACTISORB™ Silver 220 Antimicrobial Binding Dressing 10.5 × 19 cm | 3,243.6 | 508.8 | 2,734.8 (84.3) |
| 3M™ Tegaderm™ Transparent Film Dressing 10 × 12 cm | 4.4 | 28.6 | 24.2 (650) |
| 3M™ Tegaderm™ Transparent Film Dressing 10 × 25 cm | 0 | 4.9 | 4.9 (100) |
| Atrauman® Ag Silver-containing ointment dressing 10 × 10 cm | 82.8 | 510.6 | 427.8 (616.7) |
| Farmactive Alginate advanced dressing 10 × 10 cm | 17.9 | 9.8 | 8.1 (45.2) |
| ALLEVYN Hydrocellular Adhesive Dressing | 0 | 7.7 | 7.7 (100) |
| DuoDERM® Idrogel | 44.8 | 19.2 | 25.6 (57.1) |